Document:

Exhibit
10.1

 

 

October
25, 2020

 

C/O
Michael Amoroso

 

Dear
Michael,

 

This
letter agreement sets forth the terms of your employment as SVP, Chief Operating Officer effective November 1, 2020 (the
“Effective Date”).

 

		1.	Duties;
                                         Best Efforts.

 

As
the Chief Operating Officer you shall have the duties, responsibilities and authority commensurate therewith, and shall
report to the Board of Directors. You shall perform all duties and accept all responsibilities incident to such position as may
be reasonably assigned to you. You represent you are not subject to or a party to any employment agreement, noncompetition covenant,
or other agreement that would be breached by, or prohibit you from, executing this letter agreement (“Agreement”)
and performing fully your duties and responsibilities hereunder.

 

During
your employment, you will devote your best efforts and full time and attention to promote the business and affairs of the Company
and its affiliates, and shall be engaged in other business activities only to the extent that such activities do not materially
interfere or conflict with your obligations to the Company hereunder, including, without limitation, the obligations pursuant
to Section 4 below.

 

		2.	Compensation
                                         and Benefits.

 

(a)       Base
Salary. As of the Effective Date, you will receive a base salary of $475,000, as approved by the Board of Directors of the
Company (the “Board”) and payable in accordance with the regular payroll practices of the Company (“Base
Salary”).

 

(b)       Annual
Bonus. During your employment, you may be considered for an annual discretionary bonus (“Annual Bonus”)
in addition to your Base Salary, with a target of 40% of your Base Salary (“Target Annual Bonus Opportunity”).
Annual Bonus compensation in any year, if any, will be determined in the Company’s sole discretion, and shall be based on
your performance and that of the Company, as well as market factors. Except as provided below under Section 3, to be eligible
to receive an Annual Bonus as described above, you must be employed in good standing, and not have provided notice of resignation
or been provided notice of termination, on the date that the Annual Bonus is paid.

 

    	 

    	 

    

 

(c)       Equity
Compensation. In connection with your employment, and subject to Board of Directors discretion and approval, you will be entitled
to receive (i) stock option grants to purchase shares of Company common stock and (ii) other long-term equity compensation grants
(collectively, “Equity Awards”) under the Abeona Therapeutics Inc. 2015 Equity Incentive Plan (“Plan”),
subject to the terms and conditions of the Plan and the agreement memorializing the terms of the Equity Awards.

 

In
addition to the stock options previously granted to you in connection with your appointment as Senior Vice President, Chief Commercial
Officer in the amount of 250,000 stock options, on the Effective Date, the Company shall grant an additional stock option under
the Abeona Therapeutics 2015 Equity Incentive Plan (the “Option Shares”) to purchase 100,000 shares of the Company’s
Common Stock (the “Option Shares”) at an exercise price per share equal to the Fair Market Value of a share of Common
Stock (each term as defined in the Equity Incentive Plan) on the date of grant. The Option Shares will vest over a forty-eight
(48) month period, with one quarter (25%) of vesting on the one-year anniversary of the Effective Date and the remaining seventy-five
percent (75%) of the Option Shares vesting in equal monthly installments thereafter over the remaining thirty-six (36) months,
on the same date of each month as the Effective Date commencing with first such month following the first anniversary of the Effective
Date, subject to your continued employment with the Company and/or its Affiliates through to the applicable vesting dates, and
subject to the terms and conditions of the Company’s Equity Incentive Plan, except as provided below.

 

(d)       If
you remain continuously employed from the Effective Date through the date of a Change in Control (as defined below), notwithstanding
the terms of any equity incentive plan or award agreements, as applicable, all outstanding unvested stock options granted to you
during your employment with the Company shall become fully vested and exercisable and will remain exercisable for three (3) months
following the date of a Change in Control, and all outstanding long-term equity compensation awards, other than stock options,
shall become fully vested and the restrictions thereon shall lapse. Pursuant to the terms of the Plan, the exercise price of the
stock options will be the fair market value of the Company’s common stock on the date that the stock options were granted.

 

(e)       Benefits.
During your employment, you will be eligible to participate in such health and other group insurance and other employee benefit
plans and programs of the Company as are in effect from time to time, on the same basis as those in commensurate positions of
the Company. Your participation will be subject to the terms of the applicable plan documents and generally applicable Company
policies. The Company reserves the right to amend or terminate any employee benefit plan, program and policy in its discretion
at any time.

 

(f)       Paid
Time Off. You will be entitled to twenty (20) days of paid time off (vacation days plus sick time/personal time) per year, accrued
at a rate in accordance with the Company’s policies from time to time in effect, in addition to holidays observed by the
Company. Paid Time Off may be taken at such times and intervals as you shall determine, subject to the business needs of the Company
and the responsibilities of your position.

 

    2
	 

    	 

    

 

		3.	Employment
                                         Termination.

 

(a)       Termination
of Employment; Accrued Amounts. The Company may terminate your employment for any reason, and you may voluntarily terminate
your employment hereunder for any reason, in each case at any time upon written notice to the other party (the date on which your
employment terminates for any reason is herein referred to as the “Termination Date”). Upon the termination
of your employment for any reason, you (or your beneficiary or estate, as applicable, in the event of your death) will be entitled
to (i) payment of any Base Salary earned but unpaid through the Termination Date, (ii) any accrued unused vacation days, (iii)
additional vested benefits (if any) in accordance with the applicable terms of applicable Company arrangements, and (iv) any unreimbursed
expenses in accordance with the Company’s business expense reimbursement policies (collectively, the “Accrued Amounts”),
provided, however, that if your employment hereunder is terminated (A) by the Company without Cause (as defined
below) or (B) by you for Good Reason (as defined below), then you will be eligible to receive any Annual Bonus awarded for a prior
year, but not yet paid or due to be paid as of the Termination Date.

 

(b)       Severance.
If your employment is terminated (i) by the Company other than for Cause or (ii) by you for Good Reason (as defined below), in
addition to the Accrued Amounts and in lieu of any payments or benefits under any other Company separation policy or program,
you will be entitled to: (A) a payment equal to the sum of twelve (12) months of your Base Salary plus twelve (12) months of your
Target Annual Bonus Opportunity (the amount of such payment, the “Severance Amount”); and (B) a payment equal
to the premiums that you would pay if you elected continued health coverage under the Company’s health plan for you and
your eligible dependents for the twelve (12) month period following the Termination Date, less the applicable active employee
rate, which premiums will be calculated based on the rate determined under the COBRA rate in effect on the Termination Date (“Medical
Benefit Payment”); provided that any delays in the settlement or payment of such awards that are set forth in
the applicable award agreement and that are required under Section 409A of the Internal Revenue Code, as amended (the “Code”),
and the Treasury Regulations thereunder (“Section 409A”) shall remain in effect. The Company’s obligations
to make the payments and provide the benefits set forth in (A) and (B) in this Section 3(b) shall be conditioned upon your continued
compliance with your obligations under Section 4 below and your execution and nonrevocation of a release of claims in favor of
the Company and its affiliates in a form provided by the Company (“Release”). Notwithstanding any provision
to the contrary herein (other than the provisions of Section 7 below), and without limitation of any remedies to which the Company
may be entitled, (I) the Severance Amount shall be paid in installments in accordance with the Company’s regular payroll
practices during a nine (9) month period commencing within sixty (60) days following the Termination Date (with the first such
payment to include all installment amounts from the Termination Date), and (II) the Medical Benefit Payment shall be paid in a
lump sum within sixty (60) days following the Termination Date; provided that the Release is effective.

 

(c)       Change
in Control Termination. Notwithstanding any other provision contained herein, if your employment hereunder is terminated by
you for Good Reason (as defined below) or by the Company without Cause, in each case within twelve (12) months following a Change
in Control, in addition to the Accrued Amounts and in lieu of any payments or benefits under any other Company separation policy
or program, you will be entitled to receive (A) a payment equal to the sum of twelve (12) months of your Base Salary plus twelve
(12) months of your Target Annual Bonus Opportunity (such amount, the “CIC Severance Amount”); and (B) a payment
equal to the premiums that you would pay if you elected continued health coverage under the Company’s health plan for you
and your eligible dependents for the twelve (12) months period following the Termination Date, less the applicable active employee
rate, which premiums will be calculated based on the rate determined under the COBRA rate in effect on the Termination Date (“CIC
Medical Benefit Payment”). If the Change in Control is a “change in control event” as defined under Section
409A, (I) the CIC Severance Amount shall be paid in a lump sum within sixty (60) days following the Termination Date; and (II)
the CIC Medical Benefit Payment shall be paid in a lump sum within sixty (60) days following the Termination Date; The Company’s
obligations to provide the payments and benefits described in this Section 3(c) shall be conditioned upon your continued compliance
with your obligations under Section 4 below and your execution and delivery to the Company of an effective Release.

 

(d)        Resignation
of Positions. Upon your termination of employment with the Company for any reason, you will be deemed to have resigned, as
of the Termination Date, from all positions you then hold with the Company and its affiliates, and you agree to execute all documents
necessary to effectuate the same. 

 

    3
	 

    	 

    

 

(e)       Cooperation.
Following the termination of your employment with the Company for any reason, you will reasonably cooperate with the Company upon
request of the CEO, General Counsel, or the Board, and be reasonably available to the Company (taking into account your other
business endeavors) with respect to matters arising out of your services to the Company and its subsidiaries, including, in connection
with any legal proceeding, providing testimony and affidavits; provided, that, the Company shall make reasonable
efforts to minimize disruption of your other activities. The Company shall reimburse you for reasonable expenses incurred in connection
with such cooperation.

 

(f)       Definitions.
For purposes of this Agreement, the following terms have the following meanings:

 

(i)       “Cause”
shall mean: (A) your substantial failure to perform your duties (other than any such failure resulting from incapacity due to
physical or mental disability) that continues for fifteen (15) calendar days after written notice from the Company; (B) your failure
to comply with any valid and legal directive of the CEO or the Board (as applicable) that continues for fifteen (15) calendar
days after written notice from the Company; (C) your engagement in dishonesty, illegal conduct, or misconduct (or the discovery
of your having engaged in such conduct in the past), which, in each case, materially harms or is reasonably likely to materially
harm, reputationally, financially or otherwise, the Company or its subsidiaries; (D) your embezzlement, misappropriation, or fraud,
whether or not related to your employment with the Company; (E) your conviction of or plea of guilty or nolo contendere to a crime
that constitutes a felony; (F) your willful violation of a material policy of the Company; (G) your willful or grossly negligent
unauthorized disclosure of Confidential Information (as defined below); or (H) your material breach of any material obligation
under this Agreement or any other written agreement between you and the Company that continues for fifteen (15) calendar days
after written notice from the Company (if such breach is reasonably curable); or (I) any willful material failure by you to comply
with the Company’s written policies or written rules, as they may be in effect from time to time.

 

(ii)       “Change
in Control” shall have the meaning defined in subparagraph (ii) of the definition of such term under the Appendix in
the Plan as in effect on the date hereof.

 

(iii)       “Good
Reason” shall mean the occurrence of any of the following, in each case without your written consent: (A) a material
reduction of at least ten percent (10%) of your Base Salary other than a general reduction in Base Salary that affects all similarly
situated executives; (B) a material reduction of at least thirty percent (30%) of the Target Annual Bonus Opportunity other than
a general reduction in the Target Annual Bonus Opportunity that affects all similarly situated executives; (C) a permanent and
material relocation of your principal place of employment, which for purposes of this Agreement, means a relocation of more than
fifty (50) miles; (D) any material breach by the Company of any material provision of this Agreement; or (E) a material adverse
change in your title, authority, duties, or responsibilities (including the reporting structure applicable to you, other than
temporarily while you are physically or mentally incapacitated); provided, however, that you cannot terminate your
employment for Good Reason unless you have provided written notice to the Company of the existence of the circumstances providing
grounds for termination for Good Reason within sixty (60) calendar days following the initial existence of such grounds and the
Company has had thirty (30) calendar days from the date on which such notice is provided to cure such circumstances. If you do
not terminate your employment for Good Reason within sixty (60) calendar days after expiration of the cure period (in which the
Company shall not have so cured such grounds), then you will be deemed to have waived your right to terminate for Good Reason
with respect to such grounds.

 

    4
	 

    	 

    

 

		4.	Restrictive
                                         Covenants.

 

This
offer of employment is contingent on your signing the Company’s Policy on Insider Trading, Whistle Blower Policy, Code of
Ethics, and the standard Employee Confidentiality, Non-competition and Proprietary Information Agreement attached hereto as Exhibit
A, the terms of which are incorporated herein by reference in its entirety.

 

		5.	Conditions
                                         of Employment.

 

This
offer of employment is contingent upon your providing an I-9 Employment Verification Form. You will be required to submit documentation
that establishes your identity and employment eligibility in accordance with the U.S. Immigration and Naturalization requirements,
if appropriate. The offer of employment contained in this Agreement, and your continued employment, are contingent upon and subject
to a satisfactory background and reference check (which you hereby authorize), including but not limited to confirmation of your
stated credentials. It will be in the Company’s sole discretion at any time to determine the scope of the background and
reference check, whether and when to conduct or update such background check and reference check, and whether such check is satisfactory.

 

		6.	At-Will
                                         Employment.

 

Your
employment with the Company is at-will. This means that you will have the right to terminate your employment relationship with
the Company at any time for any reason. Similarly, the Company will have the right to terminate its employment relationship with
you at any time for any reason.

 

		7.	Section
                                         409A.

 

(a)       To
the extent applicable, it is intended that this Agreement (including all amendments hereto, if any) either meets the requirements
for exclusion from coverage under Section 409A, or alternatively complies with the requirements of Section 409A, so that the income
inclusion provisions of Section 409A(a)(1) of the Code do not apply to you. This Agreement shall be interpreted and administered
in a manner consistent with this intent.

 

(b)       To
the extent that payment of amounts under this Agreement that are subject to Section 409A are payable upon termination of your
employment, such amounts shall only be payable if such termination also constitutes a “separation from service,” within
the meaning of Section 409A, from the Company and its affiliates. If you are deemed on the date of your separation from service
to be a “specified employee” (within the meaning of Section 409A(a)(2)(B) of the Code) of the Company, then, notwithstanding
any other provision herein, with regard to any payment that is “nonqualified deferred compensation” subject to Section
409A and that is payable on account of your “separation from service,” such payment shall not be made prior to six
(6) months from the date of your separation from service, following which all payments so delayed shall be paid to you in a lump
sum without interest.

 

    5
	 

    	 

    

 

(c)       Any
taxable reimbursement of business or other expenses provided for under this Agreement that is subject to Section 409A shall be
subject to the following conditions: (i) the expenses eligible for reimbursement in one taxable year shall not affect the expenses
eligible for reimbursement in any other taxable year; (ii) the reimbursement of an eligible expense shall be made no later than
the end of the year after the year in which such expense was incurred; and (iii) the right to reimbursement shall not be subject
to liquidation or exchange for another benefit.

 

(d)       In
applying Section 409A to amounts paid pursuant to this Agreement, each payment shall be treated as a separate payment and any
right to a series of installment payments under this Agreement shall be treated as a right to a series of separate payments. Whenever
a payment under this Agreement specifies a payment period within a specified number of days, the actual date of payment within
the specified period shall be within the sole discretion of the Company. If the consideration and revocation period for the Release
spans two taxable years and any amount hereunder is “nonqualified deferred compensation” subject to Section 409A and
payable on account of your separation from service, such payment shall not be made or commence until the second taxable year.

 

		8.	Section
                                         280G.

 

In
the event of a change in ownership or control under Section 280G of the Code, if it shall be determined that any payment or distribution
in the nature of compensation (within the meaning of Section 280G(b)(2) of the Code) to or for your benefit, whether paid or payable
or distributed or distributable pursuant to the terms of this Agreement or otherwise (a “Payment”), would constitute
an “excess parachute payment” within the meaning of Section 280G of the Code, the aggregate present value of the Payments
under this Agreement shall be reduced (but not below zero) to the Reduced Amount (defined below) if and only if the Accounting
Firm (described below) determines that the reduction will provide you with a greater net after-tax benefit than would no reduction.
No reduction shall be made unless the reduction would provide you with a greater net after-tax benefit. The determinations under
this Section 8 shall be made as follows:

 

(i)       The
“Reduced Amount” shall be an amount expressed in present value which maximizes the aggregate present value
of Payments under this Agreement without causing any Payment under this Agreement to be subject to the Excise Tax (defined below),
determined in accordance with Section 280G(d)(4) of the Code. The term “Excise Tax” means the excise tax imposed
under Section 4999 of the Code, together with any interest or penalties imposed with respect to such excise tax.

 

(ii)       Payments
under this Agreement shall be reduced on a nondiscretionary basis in such a way as to minimize the reduction in the economic value
deliverable to you. Where more than one payment has the same value for this purpose and they are payable at different times, they
will be reduced on a pro-rata basis. Only amounts payable under the Agreement shall be reduced pursuant to this Section.

 

(iii)       All
determinations to be made under this Section shall be made by an independent certified public accounting firm selected by the
Company and agreed to by you immediately prior to the change in ownership or control transaction (the “Accounting Firm”).
The Accounting Firm shall provide its determinations and any supporting calculations both to the Company and you within ten (10)
days of the transaction. Any such determination by the Accounting Firm shall be binding upon the Company and you. All of the fees
and expenses of the Accounting Firm in performing the determinations referred to in this Section shall be borne solely by the
Company.

 

    6
	 

    	 

    

 

		9.	Miscellaneous.

 

(a)       All
amounts paid to you under this Agreement during or following your employment shall be subject to withholding and other employment
taxes imposed by applicable law, and the Company shall withhold from any payments under this Agreement all federal, state and
local taxes that the Company is required to withhold pursuant to any law or governmental rule or regulation. You shall be solely
responsible for the payment of all taxes imposed on you relating to the payment or provision of any amounts or benefits hereunder.

 

(b)       This
Agreement may be executed by .pdf or facsimile signatures in any number of counterparts, each of which shall be deemed an original,
but all such counterparts shall together constitute one and the same instrument.

 

(c)       From
and after the Effective Date, this Agreement (including Exhibit A hereto) constitutes the entire agreement between you
and the Company, and supersedes all prior representations, agreements and understandings (including any prior course of dealings),
both written and oral, between you and the Company with respect to the subject matter hereof. In the event of any inconsistency
between this Agreement and any other plan, program, practice or agreement in which you are a participant or a party, this Agreement
shall control unless such other plan, program, practice or agreement is more favorable to you (term by term) or specifically refers
to this Agreement as not controlling.

 

(d)       This
Agreement and any of the provisions hereof may be amended, waived (either generally or in a particular instance and either retroactively
or prospectively), modified or supplemented, in whole or in part, only by written agreement signed by you and the Company. This
Agreement and your rights and obligations hereunder, may not be assigned by you, and any purported assignment by you in violation
hereof shall be null and void. The Company is authorized to assign this Agreement to a successor to substantially all of its assets
or business. Nothing in this Agreement shall confer upon any person not a party hereto, or the legal representatives of such person,
any rights or remedies of any nature or kind whatsoever under or by reason of this Agreement, except the personal representative
of the deceased. This Agreement shall inure to the benefit of, and be binding on, the successors and assigns of each of the parties,
including, without limitation, your heirs and the personal representatives of your estate and any successor to all or substantially
all of the business and/or assets of the Company.

 

(e)       No
remedy conferred upon a party by this Agreement is intended to be exclusive of any other remedy, and each and every such remedy
shall be cumulative and shall be in addition to any other remedy given under this Agreement or now or hereafter existing at law
or in equity. Except as explicitly provided herein, no delay or omission by a party in exercising any right, remedy or power under
this Agreement or existing at law or in equity shall be construed as a waiver thereof, and any such right, remedy or power may
be exercised by such party from time to time and as often as may be deemed expedient or necessary by such party in its sole discretion.

 

(f)       This
Agreement shall be construed and enforced in accordance with, and the laws of the State of New York, without giving effect to
the conflicts of law principles thereof.

 

    7
	 

    	 

    

 

(g)       Any
reference to a Section of the Code shall be deemed to include any successor to such Section.

 

(h)       This
Agreement and the compensation payable hereunder (with the exception of earned base salary) shall be subject to any applicable
clawback or recoupment policies, share trading policies, and other policies that may be implemented by the Board from time to
time with respect to officers of the Company.

 

(i)       Any
notices required or permitted hereunder or necessary or convenient in connection herewith shall be in writing and shall be deemed
to have been given when hand delivered or mailed by registered or certified mail, if to the Company, to the CEO at the address
above, and if to you at the most recent address in the Company’s records.

 

(j)       Please
acknowledge your acceptance of this offer by returning a signed copy of this Agreement. If there are any other agreements of any
type that you are aware of that may impact or limit your ability to perform your job at the Company, please let us know as soon
as possible. In accepting this offer, you represent and warrant to the Company that you are not subject to any legal or contractual
restrictions that would in any way impair your ability to perform your duties and responsibilities to the Company, and that all
information you provided to the Company is accurate and complete in all respects. This offer will remain open until June 30, 2020.

 

Formalities
aside, we are very excited to continue working with us. Your skills and experiences are a great match with our goals, and I anticipate
you being a critical part of the Company’s success.

 

	Very
    truly yours,	 
	 	 
	/s/
    Kristina Maximenko	 
	Kristina
    Maximenko	 
	Head
    of HR	 

 

I
accept this offer of employment with Abeona Therapeutics and will begin employment on November 1, 2020.

 

	Signature:	 	Date:
	 	 	 
	/s/
    Michael Amoroso 	 	10/26/2020
    

 

    8
	 

    	 

    

 

Exhibit
A

 

EMPLOYEE
CONFIDENTIALITY, NON-COMPETITION, AND

PROPRIETARY
INFORMATION AGREEMENT

 

THIS
AGREEMENT, effective as of November 1, 2020 between Abeona Therapeutics Inc., a Delaware corporation (the “Company”),
and Michael Amoroso (the “Employee”).

 

1.       Employee
will make full and prompt disclosure to the Company of all inventions, improvements, modifications, discoveries, methods, technologies,
biological materials, and developments, and all other materials, items, techniques, and ideas related directly or indirectly to
the business of the Company (collectively, “Intellectual Property”), whether patentable or not, made or conceived
by Employee or under Employee’s direction during Employee’s employment with the Company, whether or not made or conceived
during normal working hours, or on the premises of the Company.

 

2.       Employee
agrees that all Intellectual Property, as defined above, shall be the sole property of the Company and its assigns, and the Company
and its assigns shall be the sole owner of all patents and other rights in connection therewith. Employee hereby assigns to the
Company any rights Employee may have or acquire in all Intellectual Property and all related patents, copyrights, trademarks,
trade names, and other industrial and intellectual property rights and applications therefore, in the United States and elsewhere.
Employee further agrees that with regard to all future developments of Intellectual Property, Employee will assist the Company
in every way that may be reasonably required by the Company (and at the Company’s expense) to obtain and, from time to time,
enforce patents on Intellectual Property in any and all countries that the Company may require, and to that end, Employee will
execute all documents for use in applying for and obtaining such patents thereon and enforcing the same, as the Company may desire,
together with any assignment thereof to the Company or persons designated by the Company, and Employee hereby appoints the Company
as Employee’s attorney to execute and deliver any such documents or assignments requested by the Company. Employee’s
obligation to assist the Company in obtaining and enforcing patents for Intellectual Property in any and all countries shall continue
beyond the termination of Employee’s employment with the Company, but the Company shall compensate Employee at a reasonable,
standard hourly rate following such termination for time directly spent by Employee at the Company’s request for such assistance.

 

3.       Employee
hereby represents that Employee has no continuing obligation to assign to any former employer or any other person, corporation,
institution, or firm any Intellectual Property as described above. Employee represents that Employee’s performance of all
the terms of this Agreement and as an employee of the Company does not and will not breach any agreement to keep in confidence
proprietary information acquired by Employee, in confidence or in trust, prior to Employee’s employment by the Company.
Employee has not entered into, and Employee agrees not to enter into, any agreement (either written or oral), which would put
Employee in conflict with this Agreement.

 

4.       Employee
agrees to assign to the Company any and all copyrights and reproduction rights to any material prepared by Employee in connection
with this Agreement and developed during the term of Employee’s employment with the Company.

 

    A-1
	 

    	 

    

 

5.       Employee
understands and agrees that a condition of Employee’s employment and continued employment with the Company is that Employee
has not brought and will not bring to the Company or use in the performance of Employee’s duties at the Company any materials
or documents rightfully belonging to a former employer which are not generally available to the public. 

 

6.       Employee
recognizes that the services to be performed by Employee hereunder are special, unique, and extraordinary and that, by reason
of Employee’s employment with the Company, Employee may acquire Confidential Information (as hereinafter defined) concerning
the operation of the Company, the use or disclosure of which would cause the Company substantial loss and damage which could not
be readily calculated and for which no remedy at law would be adequate. Accordingly, except as provided in the last Paragraph
in this Section 6, Employee agrees that Employee will not (directly or indirectly) at any time, whether during or after Employee’s
employment with the Company:

 

	 	(i)	knowingly
    use for personal benefit or for any other reason not authorized by the Company any Confidential Information that Employee
    may acquire or has acquired by reason of Employee’s employment with the Company, or;
	 	 	 
	 	(ii)	disclose
    any such Confidential Information to any person or entity except (A) in the performance of Employee obligations to the Company
    hereunder, (B) as required by a court of competent jurisdiction or as permitted below, or (C) with the prior consent of the
    Chief Executive Officer of the Company.

 

As
used herein, “Confidential Information” includes, for example and without limitation, information with respect
to the facilities and methods of the Company, reagents, chemical compounds, cell lines or subcellular constituents, organisms,
or other biological materials, trade secrets, and other Intellectual Property, systems, patents and patent applications, procedures,
manuals, confidential reports, financial information, business plans, prospects, or opportunities, personnel information, or lists
of customers and suppliers; provided, however, that Confidential Information shall not include any information that
is known or becomes generally known or available publicly (a) other than as a result of disclosure by Employee which is not permitted
as described in clause (ii) above, (b) as a result of wrongful conduct of a third party, or (c) because the Company discloses
such Confidential Information to others without obtaining an agreement of confidentiality.

 

    A-2
	 

    	 

    

 

Nothing
in this Agreement shall prohibit or restrict Employee from lawfully (a) initiating communications directly with, cooperating with,
providing information to, causing information to be provided to, or otherwise assisting in an investigation by any governmental
or regulatory agency, entity, or officials, including the Food and Drug Administration, the Securities and Exchange Commission
and the Equal Employment Opportunity Commission (collectively, “Governmental Authorities”) regarding a possible
violation of any law; (b) responding to any inquiry or legal process directed to Employee individually (and not directed to the
Company) from any such Governmental Authorities; (c) testifying, participating or otherwise assisting in an action or proceeding
by any such Governmental Authorities relating to a possible violation of law; or (d) making any other disclosures that are protected
under the whistleblower provisions of any applicable law. Notwithstanding the foregoing, Employee agrees that in making any such
disclosures or communications, Employee will take all reasonable precautions to prevent any unauthorized use or disclosure of
any information that may constitute Company Confidential Information to any parties other than any Governmental Authority. Employee
further understands that Employee is not permitted to disclose the Company’s attorney-client privileged communications or
attorney work product unless required by applicable law. Additionally, pursuant to the federal Defend Trade Secrets Act of 2016,
Employee shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade
secret that: (i) is made (A) in confidence to a federal, state, or local government official, either directly or indirectly, or
to an attorney; and (B) solely for the purpose of reporting or investigating a suspected violation of law; or (ii) is made to
Employee’s attorney in relation to a lawsuit for retaliation against Employee for reporting a suspected violation of law;
or (iii) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. Nor
does this Agreement require Employee to obtain prior authorization from the Company before engaging in any conduct described in
this Paragraph, or to notify the Company that you have engaged in any such conduct.

 

7.       During
the term of Employee’s employment with the Company and for one (1) year thereafter (the “Restricted Period”),
the Employee shall not, without the Company’s written consent, directly or indirectly, for Employee’s own account
or for the account of others, act as an officer, director, stockholder (other than as the holder of less than 1% of the outstanding
stock of any publicly traded company), owner, partner, employee, promoter, investor, consultant, manager or otherwise participate
in the promotion, financing, ownership, operation, or management of, or assist in or carry on through proprietorship, a corporation,
partnership, or other form of business entity which is in competition with the Company, within the United States or any other
country, in the fields of gene and cell therapy (a) that the Company is engaged in or has engaged in within one (1) year prior
to the Employee’s separation from the Company, or (b) in which the Company is actively seeking or planning to conduct Company
Business as of the date of such termination (the “Company Business”), and (c) about which the Employee possesses or
has had access to confidential information.

 

During
the Restricted Period, the Employee shall not, whether for Employee’s own account or for the account of any other person
(excluding the Company): (i) solicit or contact in an effort to do business with any person who was or is a customer or prospective
customer (i.e., any individual or entity with whom the Company was actively engaged in soliciting to do business) of the Company,
or any affiliate of the Company, at the time of Employee’s termination or at any time during the two (2) year period prior
to Employee’s termination, if such solicitation or contact is for the purpose of competition with the Company; or (ii) solicit
or induce any of the Company’s employees to leave their employment with the Company or accept employment with anyone else,
or hire any such employees or persons who were employed by the Company during the preceding twelve (12) months.

 

Nothing
herein shall prohibit or preclude the Employee from performing any other types of services that are not precluded by this Section
7 for any other person.

 

    A-3
	 

    	 

    

 

Employee
has carefully read and considered the provisions of this Section 7 (including the Restricted Period, scope of activity to be restrained,
and the restriction’s geographical scope) and concluded them to be fair, appropriate and reasonably required for the protection
of the legitimate business interests of the Company, its officers, directors, employees, creditors, and shareholders. Employee
understands that the restrictions contained in this Section 7 may limit Employee’s ability to engage in a business similar
to the Company’s business, but acknowledges that Employee will receive adequate and affluent remuneration and other benefits
from the Company hereunder to justify such restrictions.

 

The
Employee shall give prompt notice to the Company of the Employee’s acceptance of employment or other fees for services relationship
during the Restricted Period, which notice shall include the name of, the business of, and the position that Employee shall hold
with such other employer. Employee also agrees to inform any prospective employer or business entity or person of the restrictions
set forth in this Agreement prior to accepting employment or entering into any business relationship.

 

8.       In
the event that Employee’s employment is transferred by the Company to a subsidiary, affiliated company, or acquiring company
(as the case may be), Employee’s employment by such company will, for the purpose of this Agreement, be considered as continued
employment with the Company, unless Employee executes an agreement, substantially similar in substance to this Agreement, and
until the effective date of said agreement in any such company for which Employee becomes employed Employee agrees to be bound
by and comply with Employee’s obligations under this Agreement. It is likewise agreed that no changes in Employee’s
position or title will operate to terminate the provisions of this Agreement unless expressly agreed to in writing.

 

9.       Employee
confirms that all Confidential Information is the exclusive property of the Company. All business records, papers, documents and
electronic materials kept or made by Employee relating to the business of the Company which comprise Confidential Information
shall be and remain the property of the Company during the Employee’s employment and at all times thereafter. Upon the termination,
for any reason, of Employee’s employment with the Company, or upon the request of the Company at any time, Employee shall
deliver to the Company, and shall retain no copies of any written or electronic materials, records and documents made by Employee
or coming into Employee’s possession concerning the business or affairs of the Company and which comprise Confidential Information.
To the extent that, upon termination, Employee has any Confidential Information or other proprietary material of the Company stored
within any smart phone or personal computer, email account, thumb drive or other storage device or cloud storage, Employee agrees
to fully cooperate with the Company to return such information and material and subsequently permanently delete and remove such
information and material from such devices (subject to any litigation preservation directive in effect), including, as necessary,
providing access by the Company to such devices to ensure compliance with this Paragraph. Employee further agrees, upon termination
of Employee’s employment for any reason, unless such employment is transferred to a subsidiary, affiliated or acquiring
company of the Company, Employee agrees to return to the Company all equipment, tools or other devices owned by the Company, that
are then in Employee’s possession, however such items were obtained, and Employee agrees not to reproduce or otherwise retain
any document or data relating thereto.

 

    A-4
	 

    	 

    

 

10.       Subject
to Section 6 with respect to disclosure to Governmental Authorities, Employee agrees and covenants that he will not at any time
make, publish or communicate to any person or entity or in any public forum any defamatory or disparaging remarks, comments, or
statements concerning the Company or its businesses, or any of its employees, officers, and existing and prospective customers,
suppliers, investors and other associated third parties.

 

11.       Employee’s
obligations under this Agreement shall survive the termination of Employee’s employment with the Company regardless of the
manner of, and reason for, such termination or resignation, and shall be binding upon Employee’s heirs, executors, and administrators.

 

12.       Prior
to entering the employ of the Company, Employee has lawfully terminated employment with all previous employers. Employee acknowledges
that this Agreement does not constitute a contract of employment for a term and does not otherwise imply that the Company will
continue his or her employment for any period of time, and the nature of Employee’s employment with the Company is at-will.

 

13.       Employee
agrees that there is no Intellectual Property relevant to the subject matter of Employee’s employment with the Company,
which has been made or conceived or first reduced to practice by Employee alone or jointly with others prior to Employee’s
employment with the Company, which Employee desires to exclude from Employee’s obligations under this Agreement.

 

14.       No
delay or omission by the Company in exercising any right under this Agreement will operate as a waiver of that or any other right.
A waiver or consent given by the Company on any one occasion is effective only in that instance and will not be construed as a
bar to or waiver of any right on any other occasion.

 

15.       Employee
agrees that in addition to any other rights and remedies available to the Company for any breach or threatened breach by Employee
of Employee’s obligations hereunder, the Company shall be entitled to enforcement of Employee’s obligations hereunder
by whatever means are at the Company’s disposal, including court injunction, without having to post a bond or other security.
In the event of any such breach by Employee, the Company shall be entitled to recover all damages permitted by law in addition
to its reasonably incurred costs and attorney’s fees in enforcing its rights hereunder, and the Restricted Period shall
be extended by the period of any such breach.

 

16.       The
Company may assign this Agreement to any other corporation or entity which acquires (whether by purchase, merger, consolidation
or otherwise) all or substantially all of the business and/or assets of the Company. Employee shall have no rights of assignment.

 

17.       If
any provision of this Agreement shall be declared invalid, illegal, or unenforceable, then such provision shall be enforceable
to the extent that a court deems it reasonable to enforce such provision. If such provision shall be unreasonable to enforce to
any extent, such provision shall be severed and all remaining provisions shall continue in full force and effect.

 

    A-5
	 

    	 

    

 

18.       Employee
hereby acknowledges receipt of the Company’s Confidentiality Policy.

 

19.       This
Agreement shall be effective as of the date set forth below next to Employee’s signature.

 

20.       This
Agreement and the employment offer letter constitute the entire contract between the parties hereto with regard to the subject
matter hereof. They supersede any other agreements, representations or understandings (whether oral or written and whether express
or implied) which relate to the subject matter hereof.

 

21.       This
Agreement shall be governed in all respects by the laws of the State of New York. Each of the Company and Employee (a) hereby
irrevocably submits to the exclusive jurisdiction of the state courts of the State of New York or the United States District Court
for the Southern District of New York for the purpose of any action between the Company and Employee arising in whole or in part
under or in connection with this Agreement, (b) hereby waives, to the extent not prohibited by applicable law, and agrees not
to assert, by way of motion, as a defense or otherwise, in any such action, any claim that it is not subject personally to the
jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that any such action
brought in one of the above-named courts should be dismissed on grounds of forum non conveniens, should be transferred or removed
to any court other than one of the above-named courts, or should be stayed by reason of the pendency of some other proceeding
in any other court other than one of the above-named courts, or that this Agreement or the subject matter hereof may not be enforced
in or by such court, and (c) hereby agrees not to commence any such action other than before one of the above-named courts. Notwithstanding
the previous sentence, the Company or Employee may commence any action in a court other than the above-named courts solely for
the purpose of enforcing an order or judgment issued by one of the above-named courts.

 

IN
WITNESS WHEREOF, Employee has executed this Agreement under seal as of the date set forth above:

 

	 	 	EMPLOYEE
	 	 	 	 
	 	 	By:	/s/
    Michael Amoroso
	 	 	Name:	Michael
    Amoroso
	 	 	 	 
	ACCEPTED
    AND AGREED TO BY THE COMPANY:	 	 
	 	 	 	 
	By:	/s/
    Kristina Maximenko	 	 
	Name:	Kristina
    Maximenko	 	 
	Title:	Head
    of HR	 	 

 

    A-6Exhibit 10.8

 

INDEMNIFICATION
AGREEMENT

 

THIS INDEMNIFICATION
AGREEMENT (the “Agreement”) is made and entered into as of ____________ between Olema Pharmaceuticals, Inc.,
a Delaware corporation (the “Company”), and ______________ (“Indemnitee”).

 

WITNESSETH THAT:

 

WHEREAS, highly
competent persons have become more reluctant to serve corporations as directors, officers or in other capacities unless they are
provided with adequate protection through insurance or adequate indemnification against inordinate risks of claims and actions
against them arising out of their service to and activities on behalf of the corporation;

 

WHEREAS, the
Board of Directors of the Company (the “Board”) has determined that, in order to attract and retain qualified
individuals, the Company will attempt to maintain on an ongoing basis, at its sole expense, liability insurance to protect persons
serving the Company and its subsidiaries from certain liabilities. Although the furnishing of such insurance has been a customary
and widespread practice among United States-based corporations and other business enterprises, the Company believes that, given
current market conditions and trends, such insurance may be available to it in the future only at higher premiums and with more
exclusions. At the same time, directors, officers, and other persons in service to corporations or business enterprises are being
increasingly subjected to expensive and time-consuming litigation relating to, among other things, matters that traditionally would
have been brought only against the Company or business enterprise itself. The Bylaws and Certificate of Incorporation of the Company
require indemnification of the officers and directors of the Company. Indemnitee may also be entitled to indemnification pursuant
to the General Corporation Law of the State of Delaware (“DGCL”). The Bylaws and Certificate of Incorporation
and the DGCL expressly provide that the indemnification provisions set forth therein are not exclusive, and thereby contemplate
that contracts may be entered into between the Company and members of the Board, officers and other persons with respect to indemnification;

 

WHEREAS, the
uncertainties relating to such insurance and to indemnification have increased the difficulty of attracting and retaining such
persons;

 

WHEREAS, the
Board has determined that the increased difficulty in attracting and retaining such persons is detrimental to the best interests
of the Company’s stockholders and that the Company should act to assure such persons that there will be increased certainty
of such protection in the future;

 

WHEREAS, it
is reasonable, prudent and necessary for the Company contractually to obligate itself to indemnify, and to advance expenses on
behalf of, such persons to the fullest extent permitted by applicable law so that they will serve or continue to serve the Company
free from undue concern that they will not be so indemnified;

 

WHEREAS, this
Agreement is a supplement to and in furtherance of the Bylaws and Certificate of Incorporation of the Company and any resolutions
adopted pursuant thereto, and shall not be deemed a substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder;

 

    1

     

    

 

WHEREAS, Indemnitee
does not regard the protection available under the Company’s Bylaws and Certificate of Incorporation and insurance as adequate
in the present circumstances, and may not be willing to serve as an officer or director without adequate protection, and the Company
desires Indemnitee to serve in such capacity. Indemnitee is willing to serve, continue to serve and to take on additional service
for or on behalf of the Company on the condition that he or she be so indemnified; and

 

[WHEREAS, Indemnitee
has certain rights to indemnification and/or insurance provided by ________________ (“Fund”), which Indemnitee
and Fund intend to be secondary to the primary obligation of the Company to indemnify Indemnitee as provided herein, with the Company’s
acknowledgement and agreement to the foregoing being a material condition to Indemnitee’s willingness to serve on the Board.]

 

NOW, THEREFORE,
in consideration of Indemnitee’s agreement to serve as an officer or director from and after the date hereof, the parties
hereto agree as follows:

 

1.            Indemnity
of Indemnitee. The Company hereby agrees to hold harmless and indemnify Indemnitee to the fullest extent permitted by law,
as such may be amended from time to time. In furtherance of the foregoing indemnification, and without limiting the generality
thereof:

 

(a)            Proceedings
Other Than Proceedings by or in the Right of the Company. Indemnitee shall be entitled to the rights of indemnification provided
in this Section l(a) if, by reason of his or her Corporate Status (as hereinafter defined), the Indemnitee is,
or is threatened to be made, a party to or participant in any Proceeding (as hereinafter defined) other than a Proceeding by or
in the right of the Company. Pursuant to this Section 1(a), Indemnitee shall be indemnified against all Expenses
(as hereinafter defined), judgments, penalties, fines and amounts paid in settlement actually and reasonably incurred by him, or
on his or her behalf, in connection with such Proceeding or any claim, issue or matter therein, if the Indemnitee acted in good
faith and in a manner the Indemnitee reasonably believed to be in or not opposed to the best interests of the Company, and with
respect to any criminal Proceeding, had no reasonable cause to believe the Indemnitee’s conduct was unlawful.

 

(b)           Proceedings
by or in the Right of the Company. Indemnitee shall be entitled to the rights of indemnification provided in this Section 1(b) if,
by reason of his or her Corporate Status, the Indemnitee is, or is threatened to be made, a party to or participant in any Proceeding
brought by or in the right of the Company. Pursuant to this Section 1(b), Indemnitee shall be indemnified against
all Expenses actually and reasonably incurred by the Indemnitee, or on the Indemnitee’s behalf, in connection with such Proceeding
if the Indemnitee acted in good faith and in a manner the Indemnitee reasonably believed to be in or not opposed to the best interests
of the Company; provided, however, if applicable law so provides, no indemnification against such Expenses shall be made
in respect of any claim, issue or matter in such Proceeding as to which Indemnitee shall have been adjudged to be liable to the
Company unless and to the extent that the Court of Chancery of the State of Delaware shall determine that such indemnification
may be made.

 

    2

     

    

 

(c)            Indemnification
for Expenses of a Party Who is Wholly or Partly Successful. Notwithstanding any other provision of this Agreement, to the extent
that Indemnitee is, by reason of his or her Corporate Status, a party to and is successful, on the merits or otherwise, in any
Proceeding, he or she shall be indemnified to the maximum extent permitted by law, as such may be amended from time to time, against
all Expenses actually and reasonably incurred by him or on his behalf in connection therewith. If Indemnitee is not wholly successful
in such Proceeding but is successful, on the merits or otherwise, as to one or more but less than all claims, issues or matters
in such Proceeding, the Company shall indemnify Indemnitee against all Expenses actually and reasonably incurred by him or on his
behalf in connection with each successfully resolved claim, issue or matter. For purposes of this Section 1 and without
limitation, the termination of any claim, issue or matter in such a Proceeding by dismissal, with or without prejudice, shall be
deemed to be a successful result as to such claim, issue or matter.

 

2.            Additional
Indemnity. In addition to, and without regard to any limitations on, the indemnification provided for in Section 1
of this Agreement, the Company shall and hereby does indemnify and hold harmless Indemnitee against all Expenses, judgments, penalties,
fines and amounts paid in settlement actually and reasonably incurred by him or on his behalf if, by reason of his Corporate Status,
he or she is, or is threatened to be made, a party to or participant in any Proceeding (including a Proceeding by or in the right
of the Company), including, without limitation, all liability arising out of the negligence or active or passive wrongdoing of
Indemnitee. The only limitation that shall exist upon the Company’s obligations pursuant to this Agreement shall be that
the Company shall not be obligated to make any payment to Indemnitee that is finally determined (under the procedures, and subject
to the presumptions, set forth in Sections 6 and 7 hereof) to be unlawful.

 

3.            Contribution.

 

(a)            Whether
or not the indemnification provided in Sections 1 and 2 hereof is available, in respect of any threatened, pending
or completed action, suit or proceeding in which the Company is jointly liable with Indemnitee (or would be if joined in such action,
suit or proceeding), the Company shall pay, in the first instance, the entire amount of any judgment or settlement of such action,
suit or proceeding without requiring Indemnitee to contribute to such payment and the Company hereby waives and relinquishes any
right of contribution it may have against Indemnitee. The Company shall not enter into any settlement of any action, suit or proceeding
in which the Company is jointly liable with Indemnitee (or would be if joined in such action, suit or proceeding) unless such settlement
provides for a full and final release of all claims asserted against Indemnitee.

 

    3

     

    

 

(b)            Without
diminishing or impairing the obligations of the Company set forth in the preceding subparagraph, if, for any reason, Indemnitee
shall elect or be required to pay all or any portion of any judgment or settlement in any threatened, pending or completed action,
suit or proceeding in which the Company is jointly liable with Indemnitee (or would be if joined in such action, suit or proceeding),
the Company shall contribute to the amount of Expenses, judgments, fines and amounts paid in settlement actually and reasonably
incurred and paid or payable by Indemnitee in proportion to the relative benefits received by the Company and all officers, directors
or employees of the Company, other than Indemnitee, who are jointly liable with Indemnitee (or would be if joined in such action,
suit or proceeding), on the one hand, and Indemnitee, on the other hand, from the transaction or events from which such action,
suit or proceeding arose; provided, however, that the proportion determined on the basis of relative benefit may, to the
extent necessary to conform to law, be further adjusted by reference to the relative fault of the Company and all officers, directors
or employees of the Company other than Indemnitee who are jointly liable with Indemnitee (or would be if joined in such action,
suit or proceeding), on the one hand, and Indemnitee, on the other hand, in connection with the transaction or events that resulted
in such expenses, judgments, fines or settlement amounts, as well as any other equitable considerations that applicable law may
require to be considered. The relative fault of the Company and all officers, directors or employees of the Company, other than
Indemnitee, who are jointly liable with Indemnitee (or would be if joined in such action, suit or proceeding), on the one hand,
and Indemnitee, on the other hand, shall be determined by reference to, among other things, the degree to which their actions were
motivated by intent to gain personal profit or advantage, the degree to which their liability is primary or secondary and the degree
to which their conduct is active or passive.

 

(c)            The
Company hereby agrees to fully indemnify and hold Indemnitee harmless from any claims of contribution that may be brought by officers,
directors, or employees of the Company, other than Indemnitee, who may be jointly liable with Indemnitee.

 

(d)            To
the fullest extent permissible under applicable law, if the indemnification provided for in this Agreement is unavailable to Indemnitee
for any reason whatsoever, the Company, in lieu of indemnifying Indemnitee, shall contribute to the amount incurred by Indemnitee,
whether for judgments, fines, penalties, excise taxes, amounts paid or to be paid in settlement and/or for Expenses, in connection
with any claim relating to an indemnifiable event under this Agreement, in such proportion as is deemed fair and reasonable in
light of all of the circumstances of such Proceeding in order to reflect (i) the relative benefits received by the Company
and Indemnitee as a result of the event(s) and/or transaction(s) giving cause to such Proceeding and/or (ii) the
relative fault of the Company (and its directors, officers, employees and agents) and Indemnitee in connection with such event(s) and/or
transaction(s).

 

4.            Indemnification
for Expenses of a Witness. Notwithstanding any other provision of this Agreement, to the extent that Indemnitee is, by reason
of his Corporate Status, a witness, or is made (or asked) to respond to discovery requests, in any Proceeding to which Indemnitee
is not a party, he or she shall be indemnified against all Expenses actually and reasonably incurred by him or on his behalf in
connection therewith.

 

5.            Advancement
of Expenses. Notwithstanding any other provision of this Agreement, the Company shall advance all Expenses incurred by or on
behalf of Indemnitee in connection with any Proceeding by reason of Indemnitee’s Corporate Status within thirty (30) days
after the receipt by the Company of a statement or statements from Indemnitee requesting such advance or advances from time to
time, whether prior to or after final disposition of such Proceeding. Such statement or statements shall reasonably evidence the
Expenses incurred by Indemnitee and shall include or be preceded or accompanied by a written undertaking by or on behalf of Indemnitee
to repay any Expenses advanced if it shall ultimately be determined that Indemnitee is not entitled to be indemnified against such
Expenses. Any advances and undertakings to repay pursuant to this Section 5 shall be unsecured and interest free.

 

    4

     

    

 

6.            Procedures
and Presumptions for Determination of Entitlement to Indemnification. It is the intent of this Agreement to secure for Indemnitee
rights of indemnity that are as favorable as may be permitted under the DGCL and public policy of the State of Delaware. Accordingly,
the parties agree that the following procedures and presumptions shall apply in the event of any question as to whether Indemnitee
is entitled to indemnification under this Agreement:

 

(a)            To
obtain indemnification under this Agreement, Indemnitee shall submit to the Company a written request, including therein or
therewith such documentation and information as is reasonably available to Indemnitee and is reasonably necessary to determine
whether and to what extent Indemnitee is entitled to indemnification. The Secretary of the Company shall, promptly upon receipt
of such a request for indemnification, advise the Board in writing that Indemnitee has requested indemnification. Notwithstanding
the foregoing, any failure of Indemnitee to provide such a request to the Company, or to provide such a request in a timely fashion,
shall not relieve the Company of any liability that it may have to Indemnitee unless, and to the extent that, such failure actually
and materially prejudices the interests of the Company.

 

(b)            Upon
written request by Indemnitee for indemnification pursuant to the first sentence of Section 6(a) hereof, a determination
with respect to Indemnitee’s entitlement thereto shall be made in the specific case by one of the following four methods,
which shall be at the election of the Board (1) by a majority vote of the disinterested directors, even though less than a
quorum, (2) by a committee of disinterested directors designated by a majority vote of the disinterested directors, even though
less than a quorum, (3) if there are no disinterested directors or if the disinterested directors so direct, by independent
legal counsel in a written opinion to the Board, a copy of which shall be delivered to the Indemnitee, or (4) if so directed
by the Board, by the stockholders of the Company. For purposes hereof, disinterested directors are those members of the Board who
are not parties to the action, suit or proceeding in respect of which indemnification is sought by Indemnitee.

 

(c)            If
the determination of entitlement to indemnification is to be made by Independent Counsel pursuant to Section 6(b) hereof,
the Independent Counsel shall be selected as provided in this Section 6(c). The Independent Counsel shall be selected
by the Board. Indemnitee may, within ten (10) days after such written notice of selection shall have been given, deliver to
the Company a written objection to such selection; provided, however, that such objection may be asserted only on the ground
that the Independent Counsel so selected does not meet the requirements of “Independent Counsel” as defined
in Section 13 of this Agreement, and the objection shall set forth with particularity the factual basis of such assertion.
Absent a proper and timely objection, the person so selected shall act as Independent Counsel. If a written objection is made and
substantiated, the Independent Counsel selected may not serve as Independent Counsel unless and until such objection is withdrawn
or a court has determined that such objection is without merit. If, within twenty (20) days after submission by Indemnitee of a
written request for indemnification pursuant to Section 6(a) hereof, no Independent Counsel shall have been selected
and not objected to, either the Company or Indemnitee may petition the Court of Chancery of the State of Delaware or other court
of competent jurisdiction for resolution of any objection that shall have been made by the Indemnitee to the Company’s selection
of Independent Counsel and/or for the appointment as Independent Counsel of a person selected by the court or by such other person
as the court shall designate, and the person with respect to whom all objections are so resolved or the person so appointed shall
act as Independent Counsel under Section 6(b) hereof. The Company shall pay any and all reasonable fees and expenses
of Independent Counsel incurred by such Independent Counsel in connection with acting pursuant to Section 6(b) hereof,
and the Company shall pay all reasonable fees and expenses incident to the procedures of this Section 6(c), regardless
of the manner in which such Independent Counsel was selected or appointed.

 

    5

     

    

 

(d)           In
making a determination with respect to entitlement to indemnification hereunder, the person or persons or entity making such determination
shall presume that Indemnitee is entitled to indemnification under this Agreement. Anyone seeking to overcome this presumption
shall have the burden of proof and the burden of persuasion by clear and convincing evidence. Neither the failure of the Company
(including by its directors or independent legal counsel) to have made a determination prior to the commencement of any action
pursuant to this Agreement that indemnification is proper in the circumstances because Indemnitee has met the applicable standard
of conduct, nor an actual determination by the Company (including by its directors or independent legal counsel) that Indemnitee
has not met such applicable standard of conduct, shall be a defense to the action or create a presumption that Indemnitee has
not met the applicable standard of conduct.

 

(e)           Indemnitee
shall be deemed to have acted in good faith if Indemnitee’s action is based on the records or books of account of the Enterprise
(as hereinafter defined), including financial statements, or on information supplied to Indemnitee by the officers of the Enterprise
in the course of their duties, or on the advice of legal counsel for the Enterprise or on information or records given or reports
made to the Enterprise by an independent certified public accountant or by an appraiser or other expert selected with reasonable
care by the Enterprise. In addition, the knowledge and/or actions, or failure to act, of any director, officer, agent or employee
of the Enterprise shall not be imputed to Indemnitee for purposes of determining the right to indemnification under this Agreement.
Whether or not the foregoing provisions of this Section 6(e) are satisfied, it shall in any event be presumed
that Indemnitee has at all times acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the
best interests of the Company. Anyone seeking to overcome this presumption shall have the burden of proof and the burden of persuasion
by clear and convincing evidence.

 

(f)            If
the person, persons or entity empowered or selected under Section 6 to determine whether Indemnitee is entitled to
indemnification shall not have made a determination within sixty (60) days after receipt by the Company of the request therefor,
the requisite determination of entitlement to indemnification shall be deemed to have been made and Indemnitee shall be entitled
to such indemnification absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary
to make Indemnitee’s statement not materially misleading, in connection with the request for indemnification, or (ii) a
prohibition of such indemnification under applicable law; provided, however, that such sixty (60) day period may be extended
for a reasonable time, not to exceed an additional thirty (30) days, if the person, persons or entity making such determination
with respect to entitlement to indemnification in good faith requires such additional time to obtain or evaluate documentation
and/or information relating thereto; and provided further, that the foregoing provisions of this Section 6(f) shall
not apply if the determination of entitlement to indemnification is to be made by the stockholders pursuant to Section 6(b) of
this Agreement and if (A) within fifteen (15) days after receipt by the Company of the request for such determination, the
Board or the Disinterested Directors, if appropriate, resolve to submit such determination to the stockholders for their consideration
at an annual meeting thereof to be held within seventy five (75) days after such receipt and such determination is made thereat,
or (B) a special meeting of stockholders is called within fifteen (15) days after such receipt for the purpose of making such
determination, such meeting is held for such purpose within sixty (60) days after having been so called and such determination
is made thereat.

 

    6

     

    

 

(g)            Indemnitee
shall cooperate with the person, persons or entity making such determination with respect to Indemnitee’s entitlement to
indemnification, including providing to such person, persons or entity upon reasonable advance request any documentation or information
that is not privileged or otherwise protected from disclosure and that is reasonably available to Indemnitee and reasonably necessary
to such determination. Any Independent Counsel, member of the Board or stockholder of the Company shall act reasonably and in good
faith in making a determination regarding the Indemnitee’s entitlement to indemnification under this Agreement. Any costs
or expenses (including attorneys’ fees and disbursements) incurred by Indemnitee in so cooperating with the person, persons
or entity making such determination shall be borne by the Company (irrespective of the determination as to Indemnitee’s entitlement
to indemnification) and the Company hereby indemnifies and agrees to hold Indemnitee harmless therefrom.

 

(h)            The
Company acknowledges that a settlement or other disposition short of final judgment may be successful if it permits a party to
avoid expense, delay, distraction, disruption and uncertainty. In the event that any action, claim or proceeding to which Indemnitee
is a party is resolved in any manner other than by adverse judgment against Indemnitee (including, without limitation, settlement
of such action, claim or proceeding with or without payment of money or other consideration) it shall be presumed that Indemnitee
has been successful on the merits or otherwise in such action, suit or proceeding. Anyone seeking to overcome this presumption
shall have the burden of proof and the burden of persuasion by clear and convincing evidence.

 

(i)             The
termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction, or upon a
plea of nolo contendere or its equivalent, shall not (except as otherwise expressly provided in this Agreement) of itself adversely
affect the right of Indemnitee to indemnification or create a presumption that Indemnitee did not act in good faith and in a manner
that he or she reasonably believed to be in or not opposed to the best interests of the Company or, with respect to any criminal
Proceeding, that Indemnitee had reasonable cause to believe that his conduct was unlawful.

 

7.            Remedies
of Indemnitee.

 

(a)            In
the event that (i) a determination is made pursuant to Section 6 of this Agreement that Indemnitee is not entitled
to indemnification under this Agreement, (ii) advancement of Expenses is not timely made pursuant to Section 5
of this Agreement, (iii) no determination of entitlement to indemnification is made pursuant to Section 6(b) of
this Agreement within ninety (90) days after receipt by the Company of the request for indemnification, (iv) payment of indemnification
is not made pursuant to this Agreement within ten (10) days after receipt by the Company of a written request therefor, or
(v) payment of indemnification is not made within ten (10) days after a determination has been made that Indemnitee is
entitled to indemnification or such determination is deemed to have been made pursuant to Section 6 of this Agreement, Indemnitee
shall be entitled to an adjudication in an appropriate court of the State of Delaware, or in any other court of competent jurisdiction,
of Indemnitee’s entitlement to such indemnification. Indemnitee shall commence such proceeding seeking an adjudication within
one hundred eighty (180) days following the date on which Indemnitee first has the right to commence such proceeding pursuant to
this Section 7(a). The Company shall not oppose Indemnitee’s right to seek any such adjudication.

 

    7

     

    

 

(b)            In
the event that a determination shall have been made pursuant to Section 6(b) of this Agreement that Indemnitee
is not entitled to indemnification, any judicial proceeding commenced pursuant to this Section 7 shall be conducted
in all respects as a de novo trial on the merits, and Indemnitee shall not be prejudiced by reason of the adverse determination
under Section 6(b).

 

(c)            If
a determination shall have been made pursuant to Section 6(b) of this Agreement that Indemnitee is entitled to
indemnification, the Company shall be bound by such determination in any judicial proceeding commenced pursuant to this Section 7,
absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee’s
misstatement not materially misleading in connection with the application for indemnification, or (ii) a prohibition of such
indemnification under applicable law.

 

(d)            In
the event that Indemnitee, pursuant to this Section 7, seeks a judicial adjudication of his rights under, or to recover
damages for breach of, this Agreement, or to recover under any directors’ and officers’ liability insurance policies
maintained by the Company, the Company shall pay on his behalf, in advance, any and all expenses (of the types described in the
definition of Expenses in Section 13 of this Agreement) actually and reasonably incurred by him in such judicial adjudication,
regardless of whether Indemnitee ultimately is determined to be entitled to such indemnification, advancement of expenses or insurance
recovery.

 

(e)            The
Company shall be precluded from asserting in any judicial proceeding commenced pursuant to this Section 7 that the
procedures and presumptions of this Agreement are not valid, binding and enforceable and shall stipulate in any such court that
the Company is bound by all the provisions of this Agreement. The Company shall indemnify Indemnitee against any and all Expenses
and, if requested by Indemnitee, shall (within ten (10) days after receipt by the Company of a written request therefore)
advance, to the extent not prohibited by law, such expenses to Indemnitee, which are incurred by Indemnitee in connection with
any action brought by Indemnitee for indemnification or advance of Expenses from the Company under this Agreement or under any
directors’ and officers’ liability insurance policies maintained by the Company, regardless of whether Indemnitee ultimately
is determined to be entitled to such indemnification, advancement of Expenses or insurance recovery, as the case may be.

 

(f)             Notwithstanding
anything in this Agreement to the contrary, no determination as to entitlement to indemnification under this Agreement shall be
required to be made prior to the final disposition of the Proceeding.

 

    8

     

    

 

8.            Non-Exclusivity;
Survival of Rights; Insurance; Primacy of Indemnification; Subrogation.

 

(a)            The
rights of indemnification as provided by this Agreement shall not be deemed exclusive of any other rights to which Indemnitee may
at any time be entitled under applicable law, the Certificate of Incorporation, the By-laws, any agreement, a vote of stockholders,
a resolution of directors of the Company, or otherwise. No amendment, alteration or repeal of this Agreement or of any provision
hereof shall limit or restrict any right of Indemnitee under this Agreement in respect of any action taken or omitted by such Indemnitee
in his Corporate Status prior to such amendment, alteration or repeal. To the extent that a change in the DGCL, whether by statute
or judicial decision, permits greater indemnification than would be afforded currently under the Certificate of Incorporation,
By-laws and this Agreement, it is the intent of the parties hereto that Indemnitee shall enjoy by this Agreement the greater benefits
so afforded by such change. No right or remedy herein conferred is intended to be exclusive of any other right or remedy, and every
other right and remedy shall be cumulative and in addition to every other right and remedy given hereunder or now or hereafter
existing at law or in equity or otherwise. The assertion or employment of any right or remedy hereunder, or otherwise, shall not
prevent the concurrent assertion or employment of any other right or remedy.

 

(b)            To
the extent that the Company maintains an insurance policy or policies providing liability insurance for directors, officers, employees,
or agents or fiduciaries of the Company or of any other corporation, partnership, joint venture, trust, employee benefit plan or
other enterprise that such person serves at the request of the Company, Indemnitee shall be covered by such policy or policies
in accordance with its or their terms to the maximum extent of the coverage available for any director, officer, employee, agent
or fiduciary under such policy or policies. If, at the time of the receipt of a notice of a claim pursuant to the terms hereof,
the Company has directors’ and officers’ liability insurance in effect, the Company shall give prompt notice of the
commencement of such proceeding to the insurers in accordance with the procedures set forth in the respective policies. The Company
shall thereafter take all necessary or desirable action to cause such insurers to pay, on behalf of the Indemnitee, all amounts
payable as a result of such proceeding in accordance with the terms of such policies.

 

(c)            [The
Company hereby acknowledges that Indemnitee has certain rights to indemnification, advancement of expenses and/or insurance provided
by Fund and certain of its affiliates (collectively, the “Fund Indemnitors”). The Company hereby agrees (i) that
it is the indemnitor of first resort (i.e., its obligations to Indemnitee are primary and any obligation of the Fund Indemnitors
to advance expenses or to provide indemnification for the same expenses or liabilities incurred by Indemnitee are secondary), (ii) that
it shall be required to advance the full amount of expenses incurred by Indemnitee and shall be liable for the full amount of all
Expenses, judgments, penalties, fines and amounts paid in settlement to the extent legally permitted and as required by the terms
of this Agreement and the Certificate of Incorporation or Bylaws of the Company (or any other agreement between the Company and
Indemnitee), without regard to any rights Indemnitee may have against the Fund Indemnitors, and (iii) that it irrevocably
waives, relinquishes and releases the Fund Indemnitors from any and all claims against the Fund Indemnitors for contribution, subrogation
or any other recovery of any kind in respect thereof. The Company further agrees that no advancement or payment by the Fund Indemnitors
on behalf of Indemnitee with respect to any claim for which Indemnitee has sought indemnification from the Company shall affect
the foregoing and the Fund Indemnitors shall have a right of contribution and/or be subrogated to the extent of such advancement
or payment to all of the rights of recovery of Indemnitee against the Company. The Company and Indemnitee agree that the Fund Indemnitors
are express third party beneficiaries of the terms of this Section 8(c).]

 

    9

     

    

 

(d)            Except
as provided in paragraph (c) above, in the event of any payment under this Agreement, the Company shall be subrogated to the
extent of such payment to all of the rights of recovery of Indemnitee (other than against the Fund Indemnitors), who shall execute
all papers required and take all action necessary to secure such rights, including execution of such documents as are necessary
to enable the Company to bring suit to enforce such rights.

 

(e)            Except
as provided in paragraph (c) above, the Company shall not be liable under this Agreement to make any payment of amounts otherwise
indemnifiable hereunder if and to the extent that Indemnitee has otherwise actually received such payment under any insurance policy,
contract, agreement or otherwise.

 

(f)             Except
as provided in paragraph (c) above, the Company’s obligation to indemnify or advance Expenses hereunder to Indemnitee
who is or was serving at the request of the Company as a director, officer, employee or agent of any other corporation, partnership,
joint venture, trust, employee benefit plan or other enterprise shall be reduced by any amount Indemnitee has actually received
as indemnification or advancement of expenses from such other corporation, partnership, joint venture, trust, employee benefit
plan or other enterprise.

 

9.            Exception
to Right of Indemnification. Notwithstanding any provision in this Agreement, the Company shall not be obligated under this
Agreement to make any indemnity in connection with any claim made against Indemnitee:

 

(a)            for
which payment has actually been made to or on behalf of Indemnitee under any insurance policy or other indemnity provision, except
with respect to any excess beyond the amount paid under any insurance policy or other indemnity provision[, provided, that the
foregoing shall not affect the rights of Indemnitee or the Fund Indemnitors set forth in Section 8(c) above];
or

 

(b)            for
an accounting of profits made from the purchase and sale (or sale and purchase) by Indemnitee of securities of the Company within
the meaning of Section 16(b) of the Securities Exchange Act of 1934, as amended, or similar provisions of state statutory
law or common law; or

 

(c)            in
connection with any Proceeding (or any part of any Proceeding) initiated by Indemnitee, including any Proceeding (or any part of
any Proceeding) initiated by Indemnitee against the Company or its directors, officers, employees or other indemnitees, unless
(i) the Board authorized the Proceeding (or any part of any Proceeding) prior to its initiation, or (ii) the Company
provides the indemnification, in its sole discretion, pursuant to the powers vested in the Company under applicable law.

 

    10

     

    

 

10.          Duration
of Agreement. All agreements and obligations of the Company contained herein shall continue during the period Indemnitee is
an officer or director of the Company (or is or was serving at the request of the Company as a director, officer, employee or agent
of another corporation, partnership, joint venture, trust or other enterprise) and shall continue thereafter so long as Indemnitee
shall be subject to any Proceeding (or any proceeding commenced under Section 7 hereof) by reason of his Corporate
Status, whether or not he or she is acting or serving in any such capacity at the time any liability or expense is incurred for
which indemnification can be provided under this Agreement. This Agreement shall be binding upon and inure to the benefit of and
be enforceable by the parties hereto and their respective successors (including any direct or indirect successor by purchase, merger,
consolidation or otherwise to all or substantially all of the business or assets of the Company), assigns, spouses, heirs, executors
and personal and legal representatives.

 

11.          Security.
To the extent requested by Indemnitee and approved by the Board, the Company may at any time and from time to time provide security
to Indemnitee for the Company’s obligations hereunder through an irrevocable bank line of credit, funded trust or other collateral.
Any such security, once provided to Indemnitee, may not be revoked or released without the prior written consent of the Indemnitee.

 

12.          Enforcement.

 

(a)            The
Company expressly confirms and agrees that it has entered into this Agreement and assumes the obligations imposed on it hereby
in order to induce Indemnitee to serve as an officer or director of the Company, and the Company acknowledges that Indemnitee is
relying upon this Agreement in serving as an officer or director of the Company.

 

(b)            This
Agreement constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and supersedes
all prior agreements and understandings, oral, written and implied, between the parties hereto with respect to the subject matter
hereof.

 

(c)            The
Company shall not seek from a court, or agree to, a “bar order” that would have the effect of prohibiting or
limiting the Indemnitee’s rights to receive advancement of expenses under this Agreement.

 

13.          Definitions.
For purposes of this Agreement:

 

(a)            “Corporate
Status” describes the status of a person who is or was a director, officer, employee, agent or fiduciary of the Company
or of any other corporation, partnership, joint venture, trust, employee benefit plan or other enterprise that such person is or
was serving at the express written request of the Company.

 

(b)            “Disinterested
Director” means a director of the Company who is not and was not a party to the Proceeding in respect of which indemnification
is sought by Indemnitee.

 

(c)            “Enterprise”
shall mean the Company and any other corporation, partnership, joint venture, trust, employee benefit plan or other enterprise
that Indemnitee is or was serving at the express written request of the Company as a director, officer, employee, agent or fiduciary.

 

    11

     

    

 

(d)            “Expenses”
shall include all reasonable attorneys’ fees, retainers, court costs, transcript costs, fees of experts, witness fees, travel
expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery service fees and all other disbursements
or expenses of the types customarily incurred in connection with prosecuting, defending, preparing to prosecute or defend, investigating,
participating, or being or preparing to be a witness in a Proceeding, or responding to, or objecting to, a request to provide discovery
in any Proceeding. Expenses also shall include Expenses incurred in connection with any appeal resulting from any Proceeding and
any federal, state, local or foreign taxes imposed on the Indemnitee as a result of the actual or deemed receipt of any payments
under this Agreement, including without limitation the premium, security for, and other costs relating to any cost bond, supersede
as bond, or other appeal bond or its equivalent. Expenses, however, shall not include amounts paid in settlement by Indemnitee
or the amount of judgments or fines against Indemnitee.

 

(e)            “Independent
Counsel” means a law firm, or a member of a law firm, that is experienced in matters of corporation law and neither presently
is, nor in the past five years has been, retained to represent (i) the Company or Indemnitee in any matter material to either
such party (other than with respect to matters concerning Indemnitee under this Agreement, or of other indemnitees under similar
indemnification agreements), or (ii) any other party to the Proceeding giving rise to a claim for indemnification hereunder.
Notwithstanding the foregoing, the term “Independent Counsel” shall not include any person who, under the applicable
standards of professional conduct then prevailing, would have a conflict of interest in representing either the Company or Indemnitee
in an action to determine Indemnitee’s rights under this Agreement. The Company agrees to pay the reasonable fees of the
Independent Counsel referred to above and to fully indemnify such counsel against any and all Expenses, claims, liabilities and
damages arising out of or relating to this Agreement or its engagement pursuant hereto.

 

(f)            “Proceeding”
includes any threatened, pending or completed action, suit, arbitration, alternate dispute resolution mechanism, investigation,
inquiry, administrative hearing or any other actual, threatened or completed proceeding, whether brought by or in the right of
the Company or otherwise and whether civil, criminal, administrative or investigative, in which Indemnitee was, is or will be involved
as a party or otherwise, by reason of his or her Corporate Status, by reason of any action taken by him or of any inaction on his
part while acting in his or her Corporate Status; in each case whether or not he or she is acting or serving in any such capacity
at the time any liability or expense is incurred for which indemnification can be provided under this Agreement; including one
pending on or before the date of this Agreement, but excluding one initiated by an Indemnitee pursuant to Section 7
of this Agreement to enforce his rights under this Agreement.

 

14.          Severability.
The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability of any other provision.
Without limiting the generality of the foregoing, this Agreement is intended to confer upon Indemnitee indemnification rights to
the fullest extent permitted by applicable laws. In the event any provision hereof conflicts with any applicable law, such provision
shall be deemed modified, consistent with the aforementioned intent, to the extent necessary to resolve such conflict.

 

15.          Modification
and Waiver. No supplement, modification, termination or amendment of this Agreement shall be binding unless executed in writing
by both of the parties hereto. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver
of any other provisions hereof (whether or not similar) nor shall such waiver constitute a continuing waiver.

 

    12

     

    

 

16.          Notice
by Indemnitee. Indemnitee agrees promptly to notify the Company in writing upon being served with or otherwise receiving any
summons, citation, subpoena, complaint, indictment, information or other document relating to any Proceeding or matter that may
be subject to indemnification covered hereunder. The failure to so notify the Company shall not relieve the Company of any obligation
that it may have to Indemnitee under this Agreement or otherwise unless and only to the extent that such failure or delay materially
prejudices the Company.

 

17.          Notices.
All notices and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed effectively
given (a) upon personal delivery to the party to be notified, (b) when sent by confirmed electronic mail or facsimile
if sent during normal business hours of the recipient, and if not so confirmed, then on the next business day, (c) five (5) days
after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one (1) day
after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt.
All communications shall be sent:

 

(a)          To
Indemnitee at the address set forth below Indemnitee signature hereto.

 

(b)          To
the Company at:

 

Olema Pharmaceuticals, Inc.

512 2nd Street, 4th
Floor

San Francisco, CA 94107

Attention: Chief Executive Officer

 

or to such other address as may have been
furnished to Indemnitee by the Company or to the Company by Indemnitee, as the case may be.

 

18.          Counterparts.
This Agreement may be executed in two (2) or more counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same the same instrument. Counterparts may be delivered via facsimile, electronic mail (including
pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com) or other transmission
method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for
all purposes.

 

19.          Headings.
The headings of the paragraphs of this Agreement are inserted for convenience only and shall not be deemed to constitute part of
this Agreement or to affect the construction thereof.

 

20.          Governing
Law and Consent to Jurisdiction. This Agreement and the legal relations among the parties shall be governed by, and construed
and enforced in accordance with, the laws of the State of Delaware, without regard to its conflict of laws rules. The Company and
Indemnitee hereby irrevocably and unconditionally (i) agree that any action or proceeding arising out of or in connection
with this Agreement shall be brought only in the Chancery Court of the State of Delaware (the “Delaware Court”),
and not in any other state or federal court in the United States of America or any court in any other country, (ii) consent
to submit to the exclusive jurisdiction of the Delaware Court for purposes of any action or proceeding arising out of or in connection
with this Agreement, (iii) waive any objection to the laying of venue of any such action or proceeding in the Delaware Court,
and (iv) waive, and agree not to plead or to make, any claim that any such action or proceeding brought in the Delaware Court
has been brought in an improper or inconvenient forum.

 

Signature Page To Follow

 

    13

     

    

 

IN WITNESS WHEREOF,
the parties hereto have executed this Indemnification Agreement on and as of the day and year first above written. 

 

	 	COMPANY
	 	 
	 	OLEMA PHARMACEUTICALS, INC.

 

 

	 	 	 
	 	By:	 
	 	Name:
	 	Title:	 

 

 

	 	INDEMNITEE
	 	 
	 	 
	 	Name:
	 	 
	 	Address:
	 	Electronic Mail:

 

SIGNATURE PAGE

INDEMNIFICATION AGREEMENT

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00316-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00316-of-00352.parquet"}]]